BRISTOL MYERS SQUIBB CO 8-K

What Happened

• On January 12, 2026, Bristol-Myers Squibb Company announced via Form 8-K (Item 7.01, Regulation FD Disclosure) that it posted an investor presentation to its investor website (www.bms.com/investors/events-and-presentations.html). The presentation is furnished as Exhibit 99.1 to the current report.

Key Details

• Date filed: January 12, 2026.
• Presentation posted at: www.bms.com/investors/events-and-presentations.html and attached to the 8-K as Exhibit 99.1.
• Filing type: Regulation FD Disclosure (Item 7.01 on Form 8-K).
• The filing also included the cover page in Inline XBRL format.

Why It Matters

• The company used a Regulation FD 8-K to broadly distribute an investor presentation, so investors should review the posted slides for any strategic, operational, or pipeline updates. This is a formal disclosure channel (8-K) and may contain material information relevant to investment decisions.